AlbertoJoseMonteroMDMBA, CPHQ

PubMed

• 16 citations
  Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes.
  Lifen Cao, Kavin Sugumar, Eleanor Keller, Pamela Li, Lisa Rock
  Annals of Surgical Oncology. 2021-08-03
• 32 citations
  Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.
  Javier Cortes, Alberto J. Montero, Stefan Glück
  Cancer Treatment Reviews. 2012-04-01
• 10 citations
  A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.
  Tadeu Ambros, Simon B. Zeichner, John Zaravinos, Alberto J. Montero, Eugene Ahn
  Breast Cancer Research and Treatment. 2014-06-05

Journal Articles

• Re: Xie, J, Diener M, De G et al Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative...  
  Diaby V, Adunlin G, Montero AJ, J Med Econ, 2/10/2014
• Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L  
  Diaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ , Lichtenheld MG, Immunol Res, 11/12/2013
• Breast Cancer Survival Poorer in Black Women: Commentary  
  Montero AJ, Healio/HemOnc Today, 8/1/2013
• A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer  
  Tan PS, Haaland B, Montero AJ , Lopes G, Breast Cancer Res Treat, 3/31/2013
• Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal Adenocarcinomas  
  Allan BJ, Pedroso F, Gennis ER, Livingstone AS, Montero A , Lally B, Ardalan B, Koniaris LG, Solomon NL, Franceschi D, Ann Surg Oncol, 3/1/2013
• Molecular Profiling for Breast Cancer: A Comprehensive Review  
  Kittaneh M, Montero AJ , Gluck S, Biomarkers in Cancer, 1/1/2013
• Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review  
  Ochoa R, Bejarano PA, Gluck S, Montero AJ, J Med Case Rep, 11/1/2012
• Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple- Negative Metastatic Breast Cancer  
  Montero A , Gluck S, Case Rep Oncol, 9/1/2012
• Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low- dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial  
  Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ , K..., Cancer, 5/8/2012
• A Phase II Trial of nab- Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer  
  Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ , Merchan JR, Rocha Lima CM, Am J Clin Oncol, 2/2/2012
• Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective  
  Montero AJ , Diaz-Montero CM, Kyriakopoulos CE, Bronte V, Mandruzzato S, J Immunother, 2/1/2012
• Fighting fire with fire: rekindling the bevacizumab debate  
  Montero AJ, Vogel C, N Engl J Med, 1/26/2012
• Search for novel therapies for triple negative breast cancers (TNBC); analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GNRH)  
  Buchholz S, Seitz S, Engel J, Montero A, Ortmann O, Perez R, Block NL, Schally AV, Horm Mol Biol Clin Investig, 1/1/2012
• Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review  
  Montero AJ , Adams B, Diaz-Montero CM, Gluck S, Expert Review of Clinical Pharmacology, 5/1/2011
• Bayraktar UD, Chen E, Bayraktar S, Sands LR, Marchetti F, Montero AJ , Rocha-Lima CM?  
  Bayraktar UD, Chen E, Bayraktar S, Sands LR, Marchetti F, Montero AJ , Rocha-Lima CM, Cancer, 12/17/2010
• Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma  
  Yang R, Cheung MC, Byrne MM, J Xiaoling, Montero AJ , Jones C, Koniaris LG, Archives of Surgery, 1/1/2010
• Cytokines and Angiogenic Factors in Metastatic Renal Cell Cancer: Association of Pretreatment Serum Levels with Survival  
  Montero AJ , Diaz-Montero CM, Liu, J, McIntyre BW, Logothetis C, Tannir N, Ann Oncol, 10/1/2009
• Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination anti-tumor respo...  
  Salem ML, Diaz-Montero C, Alkhami, A, Montero AJ , Cole DJ, J Immunol, 2/15/2009
• Increased Levels of Circulating Myeloid-Derived Suppressor Cells in Solid Tumor Patients Correlate With Advanced Clinical Cancer Stage, Increased Tumor Burden, and Cyc...  
  Marcela Diaz-Montero C, Salem ML, Garrett-Mayer E, Cole DJ, Montero AJ, Cancer Immunol Immunother, 1/1/2009
• Gastrointestinal Stromal Tumors: Review of Molecular Biology and Clinical Implications  
  Jiang Y, Milling DL, Montero AJ, Gastrointestinal Cancer Research, 9/1/2008
• Priming of naive cells in the presence of IL-12 selectively enhances the survival of CD8 +CD62L hi cells and results in superior anti-tumor activity  
  Diaz-Montero CM, El Naggar S, El Naggar R, Al Khami A, Montero AJ , Cole DJ, Salem ML, Cancer Immunol Immunother, 4/1/2008
• Gemcitabine and taxanes in metastatic breast cancer: a systematic review  
  Gudena V, Montero AJ , Gluck S, Therapeutics and Clinical Risk Management, 1/1/2008
•  
  Deng WG, Montero AJ, Wu, KK, Arterioscler Thromb Vasc Biol, 8/1/2007
• Fatal Rhabdomyolysis as a complication of Et-743 (Yondelis) Chemotherapy for Sarcoma: Case Report and Literature Review  
  Skorupa A, Beldner M, Kraft A, Montero AJ, Cancer Biol Ther, 7/1/2007
• Metastatic Chest Wall Malignant Peripheral Nerve Sheath Tumor Responding to Sorafenib: Case Report and Literature Review  
  Gudena V, Verma N, Post G, Kizziah M, Fenning R, Montero AJ, Cancer Biol Ther, 6/1/2007
• Join now to see all